Patents by Inventor Tetsuya Ueba

Tetsuya Ueba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing cerebrospinal fluid hypovolemia
    Patent number: 11304658
    Abstract: The method for diagnosing cerebrospinal fluid hypovolemia includes injecting saline into a subdural space of a subject in a decubitus position, raising an upper body of the subject, and then determining whether the subject has headache or not, or headache of the subject is relieved or not.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: April 19, 2022
    Assignee: National University Corporation Kochi University
    Inventors: Eiichi Nakai, Tetsuya Ueba
  • METHOD FOR DIAGNOSING CEREBROSPINAL FLUID HYPOVOLEMIA
    Publication number: 20210038152
    Abstract: The method for diagnosing cerebrospinal fluid hypovolemia includes injecting saline into a subdural space of a subject in a decubitus position, raising an upper body of the subject, and then determining whether the subject has headache or not, or headache of the subject is relieved or not.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 11, 2021
    Applicant: NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY
    Inventors: Eiichi NAKAI, Tetsuya UEBA
  • Nucleic acids encoding regulators of FGF-2 transcription (RFT) and variants thereof
    Patent number: 6326484
    Abstract: The present invention is based on the discovery of genes which encode polypeptides are FGF-2 regulators of transcription (RFT). RFT-A, a negative regulator of transcription and RFT-A′ and RFT-B, positive regulators of FGF-2 traniscriptionl are provided. Also included are methods for diagnosis of prognosis for a subject having or at risk of having a disorder associated with FGF-2 and for treatment of cell proliferative disorders associated with FGF-2. Screening methods for identifying a compound which affects RTT-A polypeptide or a variant of RFT-A polypeptide and for identifying proteins that bind to RFT-A polypeptide or a variant of RFT-A are also provided.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: December 4, 2001
    Assignee: The Salk Institute for Biological Studies
    Inventors: Fred H. Gage, Tetsuya Ueba